Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
| Cluster id | Level | Cluster label | #P |
|---|---|---|---|
| 0 | 4 | ONCOLOGY//CELL BIOLOGY//BIOCHEMISTRY & MOLECULAR BIOLOGY | 2934640 |
| 236 | 3 | PROSTATE CANCER//PROSTATIC NEOPLASMS//UROL | 47933 |
| 282 | 2 | PROSTATE CANCER//PROSTATE//ANDROGEN RECEPTOR | 19095 |
| 34432 | 1 | OSTEOBLASTIC METASTASIS//RAT PROSTATE CANCER//CATTEDRA PATOL GEN | 125 |
Terms with highest relevance score |
| rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|---|
| 1 | OSTEOBLASTIC METASTASIS | authKW | 733477 | 6% | 36% | 8 |
| 2 | RAT PROSTATE CANCER | authKW | 336180 | 2% | 67% | 2 |
| 3 | CATTEDRA PATOL GEN | address | 336176 | 3% | 33% | 4 |
| 4 | 1 A 25 DIHYDROXY VITAMIN D3 | authKW | 252136 | 1% | 100% | 1 |
| 5 | ANDROGEN ABLATION REFRACTORY | authKW | 252136 | 1% | 100% | 1 |
| 6 | ANTI APOPTOTIC SIGNALING PATHWAYS | authKW | 252136 | 1% | 100% | 1 |
| 7 | ANTISURVIVAL FACTOR THERAPY | authKW | 252136 | 1% | 100% | 1 |
| 8 | BIOL NANOSCI ADV MED | address | 252136 | 1% | 100% | 1 |
| 9 | BIOMAT QUEBEC EO178 | address | 252136 | 1% | 100% | 1 |
| 10 | BONE PATHOPHYSIOLOGY | authKW | 252136 | 1% | 100% | 1 |
Web of Science journal categories |
| chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | Oncology | 853 | 43% | 0% | 54 |
| 2 | Urology & Nephrology | 666 | 22% | 0% | 27 |
| 3 | Endocrinology & Metabolism | 341 | 21% | 0% | 26 |
| 4 | Medicine, Research & Experimental | 33 | 7% | 0% | 9 |
| 5 | Cell Biology | 28 | 10% | 0% | 12 |
| 6 | Andrology | 18 | 1% | 0% | 1 |
| 7 | Biochemistry & Molecular Biology | 8 | 11% | 0% | 14 |
| 8 | Pharmacology & Pharmacy | 7 | 7% | 0% | 9 |
| 9 | Mycology | 3 | 1% | 0% | 1 |
| 10 | Orthopedics | 1 | 2% | 0% | 2 |
Address terms |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | CATTEDRA PATOL GEN | 336176 | 3% | 33% | 4 |
| 2 | BIOL NANOSCI ADV MED | 252136 | 1% | 100% | 1 |
| 3 | BIOMAT QUEBEC EO178 | 252136 | 1% | 100% | 1 |
| 4 | BRACHYTHER Y UROL | 252136 | 1% | 100% | 1 |
| 5 | ENDOCRINE NEOPLASIA HUMAN DISORDERS | 252136 | 1% | 100% | 1 |
| 6 | EXPT PSYSIOL | 252136 | 1% | 100% | 1 |
| 7 | FDN PUBL INSURANCE | 252136 | 1% | 100% | 1 |
| 8 | FDN SOCIAL INSURANCE GREECE | 252136 | 1% | 100% | 1 |
| 9 | FRIENDSHIP NEPHROL | 252136 | 1% | 100% | 1 |
| 10 | METAXA ANTICANC HOSP | 252136 | 1% | 100% | 1 |
Journals |
| chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
|---|---|---|---|---|---|
| 1 | PROSTATE | 10664 | 11% | 0% | 14 |
| 2 | ANTICANCER RESEARCH | 4684 | 15% | 0% | 19 |
| 3 | MOLECULAR MEDICINE | 2566 | 3% | 0% | 4 |
| 4 | CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY | 1999 | 1% | 1% | 1 |
| 5 | CLINICAL & EXPERIMENTAL METASTASIS | 1987 | 3% | 0% | 4 |
| 6 | EXPERT OPINION ON INVESTIGATIONAL DRUGS | 1016 | 2% | 0% | 3 |
| 7 | CANCER JOURNAL - FRANCE | 1007 | 1% | 0% | 1 |
| 8 | ONCOLOGY RESEARCH | 777 | 2% | 0% | 2 |
| 9 | CRITICAL REVIEWS IN EUKARYOTIC GENE EXPRESSION | 510 | 1% | 0% | 1 |
| 10 | JOURNAL OF CELLULAR BIOCHEMISTRY | 433 | 3% | 0% | 4 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 1 |